Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Accelerated partner therapy (APT) partner notification for people with Chlamydia trachomatis: protocol for the Limiting Undetected Sexually Transmitted infections to RedUce Morbidity (LUSTRUM) APT cross-over cluster randomised controlled trial.

Estcourt CS, Howarth AR, Copas A, Low N, Mapp F, Woode Owusu M, Flowers P, Roberts T, Mercer CH, Wayal S, Symonds M, Nandwani R, Saunders J, Johnson AM, Pothoulaki M, Althaus C, Pickering K, McKinnon T, Brice S, Comer A, Tostevin A, Ogwulu CD, Vojt G, Cassell JA.

BMJ Open. 2020 Mar 29;10(3):e034806. doi: 10.1136/bmjopen-2019-034806.

2.

Current State of International Clinical Experiences in US Prelicensure Nursing Programs.

McKinnon T, McNelis AM, de Leon K, Whitlow M, Fitzpatrick JJ.

Nurs Educ Perspect. 2019 Sep/Oct;40(5):291-294. doi: 10.1097/01.NEP.0000000000000563.

PMID:
31436692
3.

The Endeavor to Educate Nursing Students as True Global Citizens: Great Work Is Being Done but Continued Research and Scholarship Are Needed.

McNelis AM, McKinnon T.

Nurs Educ Perspect. 2019 Sep/Oct;40(5):264. doi: 10.1097/01.NEP.0000000000000564. No abstract available.

PMID:
31436687
4.

Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity.

Haire G, Egan K, Parmar K, McKinnon T, Monteith C, O'Connor H, Kevane B, Maguire P, Szklanna PB, Galligan M, Donnelly JC, Allen S, McCallion N, Hunt B, Áinle FN.

Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:19-23. doi: 10.1016/j.ejogrb.2019.07.035. Epub 2019 Jul 25.

PMID:
31415952
5.

Implementation of a cloud-based referral platform in ophthalmology: making telemedicine services a reality in eye care.

Kern C, Fu DJ, Kortuem K, Huemer J, Barker D, Davis A, Balaskas K, Keane PA, McKinnon T, Sim DA.

Br J Ophthalmol. 2020 Mar;104(3):312-317. doi: 10.1136/bjophthalmol-2019-314161. Epub 2019 Jul 18.

6.

The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Ishihara J, Ishihara A, Starke RD, Peghaire CR, Smith KE, McKinnon TAJ, Tabata Y, Sasaki K, White MJV, Fukunaga K, Laffan MA, Lutolf MP, Randi AM, Hubbell JA.

Blood. 2019 Jun 13;133(24):2559-2569. doi: 10.1182/blood.2019000510. Epub 2019 Apr 11.

PMID:
30975637
7.

Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in vitro flow assay.

Riddell A, Vinayagam S, Gomez K, Laffan M, McKinnon T.

Res Pract Thromb Haemost. 2018 Dec 7;3(1):126-135. doi: 10.1002/rth2.12166. eCollection 2019 Jan.

8.

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.

McKinnon T, Venier R, Yohe M, Sindiri S, Gryder BE, Shern JF, Kabaroff L, Dickson B, Schleicher K, Chouinard-Pelletier G, Menezes S, Gupta A, Zhang X, Guha R, Ferrer M, Thomas CJ, Wei Y, Davani D, Guidos CJ, Khan J, Gladdy RA.

Oncogene. 2018 May;37(20):2630-2644. doi: 10.1038/s41388-017-0122-y. Epub 2018 Feb 28.

PMID:
29487419
9.

Mouse podoplanin supports adhesion and aggregation of platelets under arterial shear: A novel mechanism of haemostasis.

Lombard SE, Pollitt AY, Hughes CE, Di Y, Mckinnon T, O'callaghan CA, Watson SP.

Platelets. 2018 Nov;29(7):716-722. doi: 10.1080/09537104.2017.1356919. Epub 2017 Nov 1.

PMID:
29090616
10.

Intrathyroidal carotid artery and nonrecurring right recurrent laryngeal nerve: A case report.

Baker A, Cottrill EE, Munizza O, McGillen K, McKinnon T, Goldenberg D.

Head Neck. 2017 Dec;39(12):E123-E126. doi: 10.1002/hed.24970. Epub 2017 Oct 11.

PMID:
29024099
11.

ADAMTS-13 glycans and conformation-dependent activity.

Nowak AA, O'Brien HER, Henne P, Doerr A, Vanhoorelbeke K, Laffan MA, McKinnon TAJ.

J Thromb Haemost. 2017 Jun;15(6):1155-1166. doi: 10.1111/jth.13688. Epub 2017 Apr 27.

12.

Service Learning as a Framework for Competency-Based Local/Global Health Education.

McKinnon T, Toms Smedley C, Evert J.

Ann Glob Health. 2016 Nov - Dec;82(6):1034-1042. doi: 10.1016/j.aogh.2016.11.004. No abstract available.

13.

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.

Chion A, O'Sullivan JM, Drakeford C, Bergsson G, Dalton N, Aguila S, Ward S, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Laffan M, McKinnon TA, O'Donnell JS.

Blood. 2016 Oct 13;128(15):1959-1968. Epub 2016 Aug 23.

14.

Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension.

Aldabbous L, Abdul-Salam V, McKinnon T, Duluc L, Pepke-Zaba J, Southwood M, Ainscough AJ, Hadinnapola C, Wilkins MR, Toshner M, Wojciak-Stothard B.

Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2078-87. doi: 10.1161/ATVBAHA.116.307634. Epub 2016 Jul 28.

15.

Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation.

McKinnon T, Venier R, Dickson BC, Kabaroff L, Alkema M, Chen L, Shern JF, Yohe ME, Khan J, Gladdy RA.

Oncotarget. 2015 Jun 10;6(16):14220-32.

16.

IgG4-Related Disease Presenting as a Solitary Neck Mass.

McKinnon T, Randazzo WT, Kim BD, Biddinger P, Forseen S.

J Radiol Case Rep. 2015 Feb 28;9(2):1-8. doi: 10.3941/jrcr.v9i2.1993. eCollection 2015 Feb.

17.

Contrast-Enhanced Ultrasound for Thrombus Dissolution in an In Vitro Model of Acute Deep Venous Thrombosis.

Dharmarajah B, McKinnon TA, Keravnou C, Averkiou MA, Leen EL, Davies AH.

J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):121. doi: 10.1016/j.jvsv.2014.10.017. Epub 2014 Dec 15. No abstract available.

PMID:
26993704
18.

Predictors of vitamin D status in subjects that consume a vitamin D supplement.

Levy MA, McKinnon T, Barker T, Dern A, Helland T, Robertson J, Cuomo J, Wood T, Dixon BM.

Eur J Clin Nutr. 2015 Jan;69(1):84-9. doi: 10.1038/ejcn.2014.133. Epub 2014 Jul 16.

PMID:
25028083
19.

Solution structure of the major factor VIII binding region on von Willebrand factor.

Shiltagh N, Kirkpatrick J, Cabrita LD, McKinnon TA, Thalassinos K, Tuddenham EG, Hansen DF.

Blood. 2014 Jun 26;123(26):4143-51. doi: 10.1182/blood-2013-07-517086. Epub 2014 Apr 3.

20.

The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.

Nowak AA, McKinnon TA, Hughes JM, Chion AC, Laffan MA.

J Thromb Haemost. 2014 Jan;12(1):54-61. doi: 10.1111/jth.12451.

21.

Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions.

Fallah MA, Huck V, Niemeyer V, Desch A, Angerer JI, McKinnon TA, Wixforth A, Schneider SW, Schneider MF.

Biomicrofluidics. 2013 Aug 26;7(4):44124. doi: 10.1063/1.4819746. eCollection 2013.

22.

The von Willebrand factor predicted unpaired cysteines are essential for secretion.

Shapiro SE, Nowak AA, Wooding C, Birdsey G, Laffan MA, McKinnon TA.

J Thromb Haemost. 2014 Feb;12(2):246-54. doi: 10.1111/jth.12466.

23.

International programs in United States schools of nursing: driving forces, obstacles, and opportunities.

McKinnon TH, McNelis AM.

Nurs Educ Perspect. 2013 Sep-Oct;34(5):323-8.

PMID:
24245383
24.

Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.

Starke RD, Paschalaki KE, Dyer CE, Harrison-Lavoie KJ, Cutler JA, McKinnon TA, Millar CM, Cutler DF, Laffan MA, Randi AM.

Blood. 2013 Apr 4;121(14):2773-84. doi: 10.1182/blood-2012-06-435727. Epub 2013 Jan 25.

25.

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.

Dixon BM, Barker T, McKinnon T, Cuomo J, Frei B, Borregaard N, Gombart AF.

BMC Res Notes. 2012 Oct 24;5:575. doi: 10.1186/1756-0500-5-575.

26.

Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.

Ahnström J, Andersson HM, Hockey V, Meng Y, McKinnon TA, Hamuro T, Crawley JT, Lane DA.

Blood. 2012 Dec 13;120(25):5059-62. doi: 10.1182/blood-2012-05-432005. Epub 2012 Oct 16.

PMID:
23074276
27.

Mapping the N-glycome of human von Willebrand factor.

Canis K, McKinnon TA, Nowak A, Haslam SM, Panico M, Morris HR, Laffan MA, Dell A.

Biochem J. 2012 Oct 15;447(2):217-28.

28.

Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow-based platelet adhesion.

McKinnon TA, Nowak AA, Cutler J, Riddell AF, Laffan MA, Millar CM.

J Thromb Haemost. 2012 Jul;10(7):1409-16. doi: 10.1111/j.1538-7836.2012.04760.x.

29.

O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions.

Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA.

Blood. 2012 Jul 5;120(1):214-22. doi: 10.1182/blood-2012-02-410050. Epub 2012 Apr 19.

PMID:
22517896
30.

Core principles for developing global service-learning programs in nursing.

McKinnon TH, Fealy G.

Nurs Educ Perspect. 2011 Mar-Apr;32(2):95-101.

PMID:
21667790
31.

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.

Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM.

J Nat Prod. 2011 Apr 25;74(4):664-9. doi: 10.1021/np1007262. Epub 2011 Mar 17.

PMID:
21413691
32.

Endothelial von Willebrand factor regulates angiogenesis.

Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM.

Blood. 2011 Jan 20;117(3):1071-80. doi: 10.1182/blood-2010-01-264507. Epub 2010 Nov 3.

33.

Time-resolved NMR: extracting the topology of complex enzyme networks.

Jiang Y, McKinnon T, Varatharajan J, Glushka J, Prestegard JH, Sornborger AT, Schüttler HB, Bar-Peled M.

Biophys J. 2010 Oct 6;99(7):2318-26. doi: 10.1016/j.bpj.2010.08.014.

34.

Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor.

McKinnon TA, Goode EC, Birdsey GM, Nowak AA, Chan AC, Lane DA, Laffan MA.

Blood. 2010 Jul 29;116(4):640-8. doi: 10.1182/blood-2010-02-267450. Epub 2010 Apr 23.

PMID:
20418283
35.

How to study placental vascular development?

Herr F, Baal N, Widmer-Teske R, McKinnon T, Zygmunt M.

Theriogenology. 2010 Apr 1;73(6):817-27. doi: 10.1016/j.theriogenology.2009.11.003. Epub 2009 Dec 29. Review.

PMID:
20036417
36.

Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13.

McGrath RT, McKinnon TA, Byrne B, O'Kennedy R, Terraube V, McRae E, Preston RJ, Laffan MA, O'Donnell JS.

Blood. 2010 Apr 1;115(13):2666-73. doi: 10.1182/blood-2009-09-241547. Epub 2009 Nov 24.

PMID:
19965639
37.

The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.

Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, Dell A.

J Thromb Haemost. 2010 Jan;8(1):137-45. doi: 10.1111/j.1538-7836.2009.03665.x. Epub 2009 Oct 24.

38.

Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor.

Riddell AF, Gomez K, Millar CM, Mellars G, Gill S, Brown SA, Sutherland M, Laffan MA, McKinnon TA.

Blood. 2009 Oct 15;114(16):3489-96. doi: 10.1182/blood-2008-10-184317. Epub 2009 Aug 17.

PMID:
19687512
39.

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Zanardelli S, Chion AC, Groot E, Lenting PJ, McKinnon TA, Laffan MA, Tseng M, Lane DA.

Blood. 2009 Sep 24;114(13):2819-28. doi: 10.1182/blood-2009-05-224915. Epub 2009 Jul 8.

40.

Blocking von Willebrand factor: a novel anti-platelet therapy.

Laffan M, McKinnon TA.

J Thromb Haemost. 2009 Jul;7(7):1152-4. doi: 10.1111/j.1538-7836.2009.03480.x. Epub 2009 May 8. No abstract available.

41.

In vitro spheroid model of placental vasculogenesis: does it work?

Baal N, Widmer-Teske R, McKinnon T, Preissner KT, Zygmunt MT.

Lab Invest. 2009 Feb;89(2):152-63. doi: 10.1038/labinvest.2008.126. Epub 2008 Dec 15.

42.

N-linked glycosylation of VWF modulates its interaction with ADAMTS13.

McKinnon TA, Chion AC, Millington AJ, Lane DA, Laffan MA.

Blood. 2008 Mar 15;111(6):3042-9. Epub 2007 Nov 1.

PMID:
17975018
43.

HCG in the regulation of placental angiogenesis. Results of an in vitro study.

Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT, Zygmunt M.

Placenta. 2007 Apr;28 Suppl A:S85-93. Epub 2007 Mar 26.

PMID:
17382384
44.

The gonadotropins: tissue-specific angiogenic factors?

Reisinger K, Baal N, McKinnon T, Münstedt K, Zygmunt M.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):65-80. Epub 2007 Feb 6. Review.

PMID:
17349737
45.

Intrinsic charge ladders of a monoclonal antibody in hydroxypropylcellulose-coated capillaries.

Sanzgiri RD, McKinnon TA, Cooper BT.

Analyst. 2006 Sep;131(9):1034-43. Epub 2006 Jul 6.

PMID:
17047804
46.

Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis.

O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA.

Blood. 2005 Sep 15;106(6):1988-91. Epub 2005 May 10.

PMID:
15886321
47.

HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor.

Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK.

Mol Hum Reprod. 2005 Apr;11(4):261-7. Epub 2005 Mar 4.

PMID:
15749784
48.

Scale-dependent temporal variations in stream water geochemistry.

Nagorski SA, Moore IN, McKinnon TE, Smith DB.

Environ Sci Technol. 2003 Mar 1;37(5):859-64.

PMID:
12666913
49.

Regulation of human trophoblast migration and invasiveness.

Chakraborty C, Gleeson LM, McKinnon T, Lala PK.

Can J Physiol Pharmacol. 2002 Feb;80(2):116-24. Review.

PMID:
11934254
50.

Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK.

McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK.

J Clin Endocrinol Metab. 2001 Aug;86(8):3665-74.

PMID:
11502794

Supplemental Content

Loading ...
Support Center